FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to cardiology, endocrinology, and can be used for normalising the blood microvesicle level in impaired glucose tolerance. That is ensured by graduated physical activity, and administration of metformin 500 mg twice a day. The therapeutic course is at least 5 weeks.
EFFECT: offered combination of therapeutic modalities enables normalising the blood microvesicle level in a relatively short time that promotes prevention of thrombotic complications in the case patients.
1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR BLOOD MICROVESCILE LEVEL CORRECTION IN ARTERIAL HYPERTENSION, ABDOMINAL OBESITY AND IMPAIRED GLUCOSE TOLERANCE | 2009 |
|
RU2400228C1 |
| METHOD OF BLOOD MICROVESICLE LEVEL NORMALISATION IN ARTERIAL HYPERTESION AND IMPAIRED GLUCOSE TOLERANCE | 2009 |
|
RU2398573C1 |
| METHOD FOR CORRECTION OF BLOOD MICROVESICLE LEVEL IN ARTERIAL HYPERTENSION, DYSLIPIDEMIA AND IMPAIRED GLUCOSE TOLERANCE | 2008 |
|
RU2372079C1 |
| METHOD FOR CORRECTION OF BLOOD MICROVESICLE LEVEL IN ARTERIAL HYPERTENSION WITH IMPAIRED GLUCOSE TOLERANCE | 2008 |
|
RU2373931C1 |
| METHOD OF NORMALISATION OF MICROVESICLE LEVEL IN BLOOD IN CASE OF GLUCOSE TOLERANCE DISTURBANCE | 2009 |
|
RU2394572C1 |
| METHOD FOR DECREASING BLOOD MICROVESCILE LEVEL IN ARTERIAL HYPERTENSION AND IMPAIRED GLUCOSE TOLERANCE | 2009 |
|
RU2393859C1 |
| METHOD FOR BLOOD MICROVESCILE LEVEL CORRECTION IN ABDOMINAL OBESITY AND IMPAIRED GLUCOSE TOLERANCE | 2009 |
|
RU2400204C1 |
| METHOD OF DECREASING SPONTANEOUS ERYTHROCYTE AGGREGATION IN IMPAIRED GLUCOSE TOLERANCE | 2009 |
|
RU2432147C2 |
| METHOD FOR BLOOD MICROVESCILE LEVEL CORRECTION IN ARTERIAL HYPERTENSION, DYSLIPIDEMIA AND TYPE II DIABETES MELLITUS | 2009 |
|
RU2400209C1 |
| METHOD FOR CORRECTION OF BLOOD MICROVESCILE LEVEL IN ARTERIAL HYPERTENSION, DYSLIPIDEMIA AND ABDOMINAL OBESITY | 2009 |
|
RU2400203C1 |
